1. Positron emission tomography: a financial and operational analysis.
2. Cost-effectiveness of PET imaging in clinical oncology
3. Laking G, Price P. 18-Fluorodeoxyglucose positron emission tomography (FDG-PET) and the staging of early lung cancer.Thorax2001; 56[suppl 2]:ii38 –ii44
4. The clinical use of PET—where are we now?
5. Wahl R. Clinical oncology update: the emerging role of positron emission tomography. 2. In: Devita V, Hellman S, Rosenberg S, eds.Cancer principles and practice of oncology. Philadelphia: Lippincott-Raven, 1997:3 –24